A randomized controlled trial is considered the gold standard of medicine. The logic is simple: one group gets the active substance, the other gets a placebo — and the difference shows the effect.
For this standard to work, the placebo must be inert. Saline. Water. Nothing that acts on its own.
In vaccine studies, this is systematically not the case.
What Was Actually Used as “Placebo” #
Most vaccines contain aluminum salts as adjuvants — excipients that stimulate the immune system and amplify the immune response. In clinical trials, not saline but often these very aluminum adjuvants were used as the placebo.
This means: both groups — vaccine and “placebo” — received aluminum. If both groups show similar side effects, this is classified as “no difference.” If both show similar immune responses, this is classified as “efficacy confirmed.”
This is not a marginal phenomenon. It is standard practice.
What Science Says About It #
A Cochrane-aligned meta-analysis (PubMed, 2022) concludes:
“No or little evidence of a difference between aluminium adjuvants versus placebo or no intervention when assessing serology.”
And already in 2011, the specialist literature stated clearly:
“Aluminium adjuvants should not be used as placebos in clinical trials — no scientific vindication for such practice is found in the relevant human vaccination literature.”
These are not statements from critical blogs. These are peer-reviewed publications naming a fundamental methodological error.
What This Means #
If aluminum adjuvants are not inert — if they themselves have biological effects — then all studies that used them as placebos are methodologically compromised.
The side effect profiles of both groups will look similar: because both groups received the same excipients. Real differences were systematically obscured.
This isn’t a conspiracy. It’s a design flaw that has been known for decades and continues to be practiced.
Why No Real Placebo? #
The justification is: it would be unethical to disadvantage the placebo group. That’s the same argument Pfizer used to vaccinate the BNT162b2 trial control group after 6 months — thereby eliminating the long-term control group.
But if real placebos are “unethical,” then reliable efficacy or safety data cannot be collected either. Both cannot coexist.
Sources:
- PubMed (2022): Aluminium adjuvants versus placebo in vaccine RCTs — pubmed.ncbi.nlm.nih.gov/35738649
- ResearchGate (2011): Aluminium adjuvants should not be used as placebos — researchgate.net
- Vox (2021): Covid vaccine trial — unblinding the placebo group — vox.com
- PMC Cochrane analysis: Aluminium adjuvants in vaccine trials — pmc.ncbi.nlm.nih.gov/articles/PMC9226993
